188 related articles for article (PubMed ID: 19136222)
41. Social Influences on Nicotine-Related Behaviors.
Piña JA; Namba MD; Leyrer-Jackson JM; Cabrera-Brown G; Gipson CD
Int Rev Neurobiol; 2018; 140():1-32. PubMed ID: 30193701
[TBL] [Abstract][Full Text] [Related]
42. The role of impulsivity in relapse vulnerability.
Pattij T; De Vries TJ
Curr Opin Neurobiol; 2013 Aug; 23(4):700-5. PubMed ID: 23462336
[TBL] [Abstract][Full Text] [Related]
43. Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules.
Wingo T; Nesil T; Choi JS; Li MD
J Neuroimmune Pharmacol; 2016 Sep; 11(3):456-70. PubMed ID: 26481371
[TBL] [Abstract][Full Text] [Related]
44. Sex differences in drug addiction: a review of animal and human studies.
Fattore L; Altea S; Fratta W
Womens Health (Lond); 2008 Jan; 4():51-65. PubMed ID: 19072451
[TBL] [Abstract][Full Text] [Related]
45. The addictive role of nicotine in tobacco use.
Henningfield JE; Heishman SJ
Psychopharmacology (Berl); 1995 Jan; 117(1):11-3. PubMed ID: 7724694
[No Abstract] [Full Text] [Related]
46. The validity of the reinstatement model of craving and relapse to drug use.
Katz JL; Higgins ST
Psychopharmacology (Berl); 2003 Jul; 168(1-2):21-30. PubMed ID: 12695875
[TBL] [Abstract][Full Text] [Related]
47. [Nicotine and animal models: what does the environmental enrichment paradigm tell us?].
Mesa-Gresa P; Pérez-Martínez A; Redolat-Iborra R
Adicciones; 2012; 24(2):87-94. PubMed ID: 22648311
[TBL] [Abstract][Full Text] [Related]
48. Sex differences in drug abuse.
Becker JB; Hu M
Front Neuroendocrinol; 2008 Jan; 29(1):36-47. PubMed ID: 17904621
[TBL] [Abstract][Full Text] [Related]
49. Sex-driven vulnerability in stress and drug abuse.
Berry A; Raggi C; Borgi M; Cirulli F
Ann Ist Super Sanita; 2016; 52(2):167-75. PubMed ID: 27364390
[TBL] [Abstract][Full Text] [Related]
50. The Addicted-Self Model of addictive behavior cessation: does it predict recovery for gender, ethnic, age and drug preference populations?
Fiorentine R; Hillhouse MP
Am J Addict; 2004; 13(3):268-80. PubMed ID: 15370946
[TBL] [Abstract][Full Text] [Related]
51. Methods for Evaluating the Interaction Between Social Stress and Environmental Enrichment in Animal Models of Nicotine Addiction.
Mesa-Gresa P; Duque A; Monleón S; Vinader-Caerols C; Redolat R
Methods Mol Biol; 2019; 2011():267-280. PubMed ID: 31273704
[TBL] [Abstract][Full Text] [Related]
52. Addiction: multiple expressions, common aetiologies, culturally congruent interventions.
Zywiak WH
Indian J Med Res; 2009 Dec; 130(6):675-6. PubMed ID: 20090126
[No Abstract] [Full Text] [Related]
53. Nicotine dependence--treatment for the 1990s.
Hurt RD
J Intern Med; 1993 Apr; 233(4):307-10. PubMed ID: 8463761
[TBL] [Abstract][Full Text] [Related]
54. Does physical activity protect against drug abuse vulnerability?
Bardo MT; Compton WM
Drug Alcohol Depend; 2015 Aug; 153():3-13. PubMed ID: 26091750
[TBL] [Abstract][Full Text] [Related]
55. Neurobehavioral effects of environmental enrichment and drug abuse vulnerability: An updated review.
Malone SG; Shaykin JD; Stairs DJ; Bardo MT
Pharmacol Biochem Behav; 2022 Nov; 221():173471. PubMed ID: 36228739
[TBL] [Abstract][Full Text] [Related]
56. Exercise as a potential treatment for drug abuse: evidence from preclinical studies.
Smith MA; Lynch WJ
Front Psychiatry; 2011; 2():82. PubMed ID: 22347866
[TBL] [Abstract][Full Text] [Related]
57. Translational research in medication development for nicotine dependence.
Lerman C; LeSage MG; Perkins KA; O'Malley SS; Siegel SJ; Benowitz NL; Corrigall WA
Nat Rev Drug Discov; 2007 Sep; 6(9):746-62. PubMed ID: 17690709
[TBL] [Abstract][Full Text] [Related]
58. Preclinical Abuse Potential Assessment.
Kallman MJ
Handb Exp Pharmacol; 2015; 229():115-30. PubMed ID: 26091638
[TBL] [Abstract][Full Text] [Related]
59. How to study sex differences in addiction using animal models.
Carroll ME; Lynch WJ
Addict Biol; 2016 Sep; 21(5):1007-29. PubMed ID: 27345022
[TBL] [Abstract][Full Text] [Related]
60. Acquisition of drug self-administration: environmental and pharmacological interventions.
Campbell UC; Carroll ME
Exp Clin Psychopharmacol; 2000 Aug; 8(3):312-25. PubMed ID: 10975619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
